Documente Academic
Documente Profesional
Documente Cultură
The time of diagnosis, initial stages of adjuvant treatment course and the months
immediately following the end of adjuvant treatment are transition times of poor
adjustment and decreased quality of life in breast cancer patients. Studies have shown
that decreased health-related quality of life as a result of chemotherapy side effects may
predict early treatment discontinuation in patients with breast cancer . On the other
hand studies on post-treatment adjustment of breast cancer survivors demonstrated
that breast cancer patients might enjoy from a good quality of life.
The study showed that overall breast cancer patients perceived benefit from their
adjuvant treatment. However sustained problems such as fatigue, pain, sleep
disturbances and arm symptoms were observed. Indeed, these should be managed by
targeted interventional programs. Also, impaired body image decreased sexual
functioning and sexual enjoyment in patients must be seriously considered in long-term
survivors of breast cancer to improve their overall quality of life.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588619/
2005 Nov;
Quality of life among long-term breast cancer survivors: a systematic
review.
According to Mols F, the aim of this study was to review the literature on quality of life among
long-term survivors of breast cancer and identify the specific aspects of quality of life that were
affected in these survivors. We also describe predictors of quality of life. Published research
reports were included if they described the quality of life of breast cancer survivors diagnosed at
least five years earlier. Most studies reported that long-term survivors of breast cancer
experienced good overall quality of life. However, almost all studies reported that breast cancer
survivors experienced some specific problems (e.g., a thick and painful arm and problems with
sexual functioning). The current medical condition, amount of social support and current income
level were strong positive predictors of quality of life, and the use of adjuvant chemotherapy
emerged as a negative predictor. More research on the specific medical and psychosocial
needs of survivors is needed in order to be able to design appropriate intervention studies. If
anything, this review shows that focusing on the long-term effects of breast cancer is important
when evaluating the full extent of cancer treatment.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588619/